Obsessive-compulsive disorder: advances in diagnosis and treatment

ME Hirschtritt, MH Bloch, CA Mathews - Jama, 2017 - jamanetwork.com
Importance Obsessive-compulsive disorder (OCD) is a neuropsychiatric disorder associated
with significant impairment and a lifetime prevalence of 1% to 3%; however, it is often …

Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders

MA Katzman, P Bleau, P Blier, P Chokka, K Kjernisted… - BMC psychiatry, 2014 - Springer
Background Anxiety and related disorders are among the most common mental disorders,
with lifetime prevalence reportedly as high as 31%. Unfortunately, anxiety disorders are …

Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition

B Bandelow, D Baldwin, M Abelli… - The World Journal of …, 2017 - Taylor & Francis
Objective: Biomarkers are defined as anatomical, biochemical or physiological traits that are
specific to certain disorders or syndromes. The objective of this paper is to summarise the …

Psychopharmacological treatment of obsessive-compulsive disorder (OCD)

A Del Casale, S Sorice, A Padovano… - Current …, 2019 - ingentaconnect.com
Background: Obsessive-compulsive disorder (OCD) is associated with affective and
cognitive symptoms causing personal distress and reduced global functioning. These have …

Neuroinflammation and psychiatric illness

S Najjar, DM Pearlman, K Alper, A Najjar… - Journal of …, 2013 - Springer
Multiple lines of evidence support the pathogenic role of neuroinflammation in psychiatric
illness. While systemic autoimmune diseases are well-documented causes of …

[PDF][PDF] Practice guideline for the treatment of patients with obsessive-compulsive disorder

American Psychiatric Association, LM Koran… - 2007 - academia.edu
PRACTICE GUIDELINE FOR THE TREATMENT OF PATIENTS WITH OBSESSIVE-COMPULSIVE
DISORDER Page 1 Not for Distribution or Citation Draft 2, December 6, 2005 PRACTICE …

[HTML][HTML] Treatment-resistant OCD: Pharmacotherapies in adults

PJ Van Roessel, G Grassi, EN Aboujaoude… - Comprehensive …, 2023 - Elsevier
Serotonin reuptake inhibitor (SRI) medications are well established as first-line
pharmacotherapeutic treatment for Obsessive-Compulsive Disorder (OCD). However …

Clinical management of pediatric acute-onset neuropsychiatric syndrome: part II—use of immunomodulatory therapies

J Frankovich, S Swedo, T Murphy, RC Dale… - Journal of child and …, 2017 - liebertpub.com
Abstract Introduction: Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) is a
clinically heterogeneous disorder with a number of different etiologies and disease …

Challenges and opportunities for celecoxib repurposing

U Bąk, A Krupa - Pharmaceutical Research, 2023 - Springer
Drug repositioning, also known as drug repurposing, reprofiling, or rediscovery, is
considered to be one of the most promising strategies to accelerate the development of new …

[HTML][HTML] Maternal autoimmunity and inflammation are associated with childhood tics and obsessive-compulsive disorder: transcriptomic data show common enriched …

HF Jones, VX Han, S Patel, BS Gloss, N Soler… - Brain, Behavior, and …, 2021 - Elsevier
Although genetic variation is a major risk factor of neurodevelopmental disorders,
environmental factors during pregnancy and early life are also important in disease …